Embolization Devices Market
Embolization Devices Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Embolization Devices Market Size and Growth
The global Embolization Devices market is projected to reach a value of $4.78 billion by 2024, with a CAGR of 7.1% during the forecast period. Increasing prevalence of cardiovascular diseases and advancements in minimally invasive procedures are driving market growth. North America is expected to dominate the market due to technological advancements and high healthcare expenditure. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Boston Scientific (US)
◍ Cook Medical (China)
◍ Medtronic (US)
◍ Abbott
◍ Penumbra (US)
◍ Terumo (Japan)
◍ Acandis (China)
◍ AngioDynamics (US)
◍ Angioslide (US)
◍ Contego Medical
◍ CryoLife (US)
◍ InspireMD (Israel)
◍ Phenox (Japan)
The global embolization devices market is highly competitive and includes key players such as Boston Scientific, Cook Medical, Medtronic, Abbott, Penumbra, Terumo, Acandis, AngioDynamics, Angioslide, Contego Medical, CryoLife, InspireMD, and Phenox. These companies offer a range of embolization devices to treat various medical conditions such as vascular tumors and aneurysms. They leverage innovative technologies to enhance their product offerings and expand their market presence.
Request Sample Report
- Boston Scientific: Sales revenue of $9.86 billion - Cook Medical: Sales revenue of $2.4 billion - Medtronic: Sales revenue of $30.56 billion
Market Segmentation
By Application
Hospitals
Specialty Clinics
ASCs
By Product
◍ Embolic Coils
Liquid Agents
EPDs
Flow Diverters
Access Devices
Request Sample Report
◍
◍
◍
◍
◍
◍
◍
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients